HLA Ligand Atlas DIA: extending the benign immunopeptidomics resource with increased sensitivity through data-independent acquisition mass spectrometry
Journal for ImmunoTherapy of Cancer · 2025
DOI: 10.1136/jitc-2025-012083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2025. Verfasst von Leon Bichmann und 20 weiteren Autor:innen. Beteiligte Einrichtung: Center for Systems and Engineering Immunology, Yale University, New Haven, Connecticut, USA leon.bichmann@yale.edu. Hauptthemen laut MEDLINE: Mass Spectrometry, HLA Antigens, Peptides, Proteomics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim Foundation for Basic Research in Medicine, Deutsche Forschungsgemeinschaft, Bosch-Forschungsstiftung.
Abstract (Originalsprache)
The human leukocyte antigen (HLA)-presented peptide repertoire, termed immunopeptidome, plays a crucial role for T-cell mediated immune reactions. Previously, the human immunopeptidome of non-malignant tissues has been mapped in a large-scale study, the HLA Ligand Atlas, via high-resolution data-dependent acquisition (DDA) mass spectrometry. This publicly available and user-friendly web interface ( https://hla-ligand-atlas.org ) is frequently used as a benign tissue reference in antigen discovery, especially for immunotherapy of cancer. Here, we extend the HLA Ligand Atlas resource with paired data-independent acquisition (DIA) runs for all tissue-subject combinations. This novel dataset comprises 946 DIA HLA class I and II immunopeptidomic runs from 242 non-malignant human samples across 18 subjects and 29 distinct tissues. Together with the published DDA runs, this extends the range and depth of analyses performed on the HLA Ligand Atlas dataset. In a concise analysis, we showcase advantages of DIA over DDA concerning spectral sampling and sensitivity. These findings are attributed to the increased dynamic range in DIA, enabling the identification of peptide transitions with low signal intensities. Moreover, we demonstrate the superior sensitivity by applying an HLA-A*02:01 allotype-specific spectral library search to identify and quantify HLA-presented peptides. We encourage reanalysis of the provided DDA and DIA data in combination as a reference for future research concerning human immunology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Systems and Engineering Immunology, Yale University, New Haven, Connecticut, USA leon.bichmann@yale.edu.
- Interfaculty Institute for Cell Biology and Immunology, University of Tübingen, Tübingen, Germany.
- Genentech, San Francisco, California, USA.
- Department of Peptide-based Immunotherapy, University Hospital Tübingen, Baden-Württemberg, Germany.
- Obstetrics and Gynecology, University Hospital of Tübingen, University of Tübingen, Tübingen, Germany.
- Pediatric Stem Cell Transplantation, University Children's Hospital Zurich, University Hospital Zurich, Zurich, Switzerland.
Förderung
- Boehringer Ingelheim Foundation for Basic Research in Medicine
- Deutsche Forschungsgemeinschaft
- Bosch-Forschungsstiftung
Zitieren
APA
Bichmann, L., Marcu, A., Kowalewski, D. J., Freudenmann, L. K., Backert, L., Mühlenbruch, L., Lübke, M., Wagner, P., Engler, T., Matovina, S., Hauri-Hohl, M., Martin, R., Moch, H., Regli, L., Weller, M., Löffler, M. W., Walz, J. S., Kohlbacher, O., Röst, H., …, & Neidert, M. C. (2025). HLA Ligand Atlas DIA: extending the benign immunopeptidomics resource with increased sensitivity through data-independent acquisition mass spectrometry. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-012083
Vancouver
Bichmann L, Marcu A, Kowalewski DJ, Freudenmann LK, Backert L, Mühlenbruch L, et al. HLA Ligand Atlas DIA: extending the benign immunopeptidomics resource with increased sensitivity through data-independent acquisition mass spectrometry. Journal for ImmunoTherapy of Cancer. 2025. doi:10.1136/jitc-2025-012083
BibTeX
@article{Bichmann2025,
author = {Bichmann, Leon and Marcu, Ana and Kowalewski, Daniel Johannes and Freudenmann, Lena Katharina and Backert, Linus and Mühlenbruch, Lena and Lübke, Maren and Wagner, Philipp and Engler, Tobias and Matovina, Sabine and Hauri-Hohl, Mathias and Martin, Roland and Moch, Holger and Regli, Luca and Weller, Michael and Löffler, Markus W and Walz, Juliane S and Kohlbacher, Oliver and Röst, Hannes and Rammensee, Hans-Georg and Neidert, Marian C},
title = {HLA Ligand Atlas DIA: extending the benign immunopeptidomics resource with increased sensitivity through data-independent acquisition mass spectrometry},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2025},
doi = {10.1136/jitc-2025-012083}
}
EUVIMED